Cargando…
Alterations of Phosphodiesterases in Adrenocortical Tumors
Alterations in the cyclic (c)AMP-dependent signaling pathway have been implicated in the majority of benign adrenocortical tumors (ACTs) causing Cushing syndrome (CS). Phosphodiesterases (PDEs) are enzymes that regulate cyclic nucleotide levels, including cyclic adenosine monophosphate (cAMP). Inact...
Autores principales: | Hannah-Shmouni, Fady, Faucz, Fabio R., Stratakis, Constantine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003917/ https://www.ncbi.nlm.nih.gov/pubmed/27625633 http://dx.doi.org/10.3389/fendo.2016.00111 |
Ejemplares similares
-
Molecular Genetic and Genomic Alterations in Cushing’s Syndrome and Primary Aldosteronism
por: Kamilaris, Crystal D. C., et al.
Publicado: (2021) -
Germline Variants in Phosphodiesterase Genes and Genetic Predisposition to Pediatric Adrenocortical Tumors
por: Pinto, Emilia Modolo, et al.
Publicado: (2020) -
PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors
por: Berthon, Annabel S., et al.
Publicado: (2015) -
Carney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency
por: Pitsava, Georgia, et al.
Publicado: (2021) -
SAT-350 Comparative Proteomic Analysis of Various Forms of Bilateral Adrenocortical Hyperplasia
por: Berthon, Annabel, et al.
Publicado: (2019)